⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARTV News
Artiva Biotherapeutics, Inc. Common Stock
Form 8-K
sec.gov
ARTV
Artiva Biotherapeutics Announces Strategic Update and Discontinues Development of AlloNK®
globenewswire.com
ARTV
Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at the American College of Rheumatology (ACR) Convergence 2026
globenewswire.com
ARTV
Artiva Biotherapeutics Highlights Updated AlloNK® Data in Sjögren Disease Presented at the 17th International Symposium on Sjögren’s Disease (ISSjD 2026)
globenewswire.com
ARTV
Artiva Biotherapeutics Announces Oral Presentation of AlloNK® Clinical Data at the 17th International Symposium on Sjögren’s Disease
globenewswire.com
ARTV
Artiva Biotherapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum
globenewswire.com
ARTV
Form 8-K
sec.gov
ARTV
Artiva Biotherapeutics Provides Update on Planned AlloNK® Data Disclosures and Development Milestones for the Remainder of 2026
globenewswire.com
ARTV
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September
globenewswire.com
ARTV
Form 8-K
sec.gov
ARTV